Table 3.
Variablea | Placebo (n=11) |
Active (n=10) |
P-value |
---|---|---|---|
VAS pain score at rest hour 0 | 1 (0, 0, 6, 10)b | 0 (0, 0, 6, 10) | 0.85 |
VAS pain score at rest hour 2 | 2 (0, 0, 5, 10) | 1 (0, 0, 3, 6) | 0.61 |
VAS pain score at rest hour 6 | 2 (0, 1, 5, 10) | 3 (0, 2, 4, 6) | 0.89 |
VAS pain score at rest hour 12 | 3 (1, 1, 4, 10) | 2 (0, 1, 5, 5) | 0.47 |
VAS pain score at rest hour 24 | 4 (0, 2, 6, 8) | 1 (0, 0, 2, 4) | 0.017 |
VAS pain score with bending knee hour 0 | 1 (0, 0, 6, 10)b | 0 (0, 0, 6, 10) | 0.85 |
VAS pain score with bending knee hour 2 | 2 (0, 0, 6, 10)b | 1 (0, 0, 4, 6) | 0.68 |
VAS pain score with bending knee hour 6 | 2 (0, 0, 5, 10) | 3 (0, 0, 4, 7) | 0.97 |
VAS pain score with bending knee hour 12 | 4 (0, 1, 6, 10) | 3 (0, 0, 5, 7) | 0.62 |
VAS pain score with bending knee hour 24 | 5 (2, 3, 7, 10) | 1 (0, 0, 2, 6) | 0.002 |
Notes:
Continuous variables are reported with median (minimum, 25th percentile, 75th percentile, maximum)
information was not collected for one patient
P-value given based on Wilcoxon rank sum test.
Abbreviation: VAS, visual analog scale.